Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0IL0J
|
|||
Drug Name |
US9522888, 695
|
|||
Synonyms |
SCHEMBL17511431; BDBM258469; US9522888, 695
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H34NO5P
|
|||
Canonical SMILES |
CCOCCCC1CCC2=C(C1)C=CC(=C2)C3CCC(C3)(COP(=O)(O)O)N
|
|||
InChI |
1S/C21H34NO5P/c1-2-26-11-3-4-16-5-6-18-13-19(8-7-17(18)12-16)20-9-10-21(22,14-20)15-27-28(23,24)25/h7-8,13,16,20H,2-6,9-12,14-15,22H2,1H3,(H2,23,24,25)/t16-,20+,21-/m1/s1
|
|||
InChIKey |
VHKORLDZIRFKDI-TYCQWZJGSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sphingosine-1-phosphate receptor 3 (S1PR3) | Target Info | Inhibitor | [1] |
Target's Patent Info | Sphingosine-1-phosphate receptor 3 (S1PR3) | Target's Patent Info | [1] | |
KEGG Pathway | Sphingolipid signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Pathway Interaction Database | S1P3 pathway | |||
Sphingosine 1-phosphate (S1P) pathway | ||||
Reactome | G alpha (i) signalling events | |||
Lysosphingolipid and LPA receptors | ||||
WikiPathways | Signal Transduction of S1P Receptor | |||
Small Ligand GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Substituted bicyclic compounds. US9522888. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.